GlaxoSmithKline
GSK
#209
Rank
C$136.89 B
Marketcap
C$67.85
Share price
0.88%
Change (1 day)
46.83%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: C$136.89 Billion

As of December 2025 GlaxoSmithKline has a market cap of C$136.89 Billion. This makes GlaxoSmithKline the world's 209th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025C$136.89 B37.2%
2024C$99.77 B-1.34%
2023C$101.13 B3.61%
2022C$97.61 B-29.8%
2021C$139.04 B18.84%
2020C$117.00 B-23.03%
2019C$152.00 B18.79%
2018C$127.96 B15.5%
2017C$110.78 B-12.5%
2016C$126.61 B-7.85%
2015C$137.41 B13.67%
2014C$120.88 B-11.98%
2013C$137.33 B30.57%
2012C$105.17 B-10.24%
2011C$117.17 B15.04%
2010C$101.85 B-11.72%
2009C$115.38 B-1.83%
2008C$117.53 B-15.11%
2007C$138.45 B-21.68%
2006C$176.78 B3.04%
2005C$171.57 B1.53%
2004C$168.98 B-1.08%
2003C$170.82 B-4.14%
2002C$178.21 B-27.25%
2001C$244.96 B-7.19%
2000C$263.92 B79.91%
1999C$146.70 B-24.27%
1998C$193.71 B58.44%
1997C$122.26 B58.59%
1996C$77.09 B

End of Day market cap according to different sources

On Dec 14th, 2025 the market cap of GlaxoSmithKline was reported to be:

C$137.15 Billion
by Nasdaq info icon info icon
C$135.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
C$391.15 B 185.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$207.05 B 51.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$345.05 B 152.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$357.41 B 161.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$160.83 B 17.48%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
C$47.62 B-65.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
C$1.75 B-98.72%๐Ÿ‡บ๐Ÿ‡ธ USA